OSSTEC
OSSTEC Ltd is a London-based orthopaedic device company spun out of Imperial College London that develops 3D-printed cementless partial knee implants using biomimetic fixation, selling to hospitals and orthopaedic surgeons and preparing for US market entry pending FDA clearance.
- Company typePrivate
- Founded2021
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What OSSTEC does
OSSTEC Ltd is a UK-based orthopaedic medical device company incorporated in England and Wales and headquartered at Imperial College London, London, from which it spun out. The company develops 3D-printed knee implants built on a biomimetic cementless fixation platform that the company claims reduces the risk of implant loosening by approximately 50% compared with cemented alternatives and addresses a 35% long-term failure rate in younger, more active patients. Its flagship offering, the ASCENT Cementless Partial Knee System, combines novel 3D-printed articulating surfaces with cementless biologic fixation derived from roughly a decade of research at Imperial College London.
OSSTEC generates revenue through hardware sales of its implants to hospitals and surgical centres via enterprise field sales and direct hospital distribution, with pricing negotiated through hospital procurement. The go-to-market is targeted at orthopaedic surgeons performing partial knee replacement, a procedure it estimates is appropriate for about 50% of knee replacement candidates based on its published content. The company is led by surgeons and engineers, including CTO & Co-Founder Jonathan Jeffers, Founder & CEO Maxwell Munford, and Chair Dominique Kleyn, with clinical endorsement from academic surgeons such as Mr. Alex Liddle (DPhil FRCS(Orth)).
The company remains at an early commercial stage: it employs 1-10 people, has raised a £2.5 million seed round in April 2025 alongside earlier seed capital, and is actively pursuing FDA regulatory clearance for the ASCENT system ahead of a US launch. In February 2026 it closed additional funding anchored by Embryo Ventures, appointed Christopher Campbell as US Commercial Lead to lead dedicated US operations, and added Dr. Nick Pachuda as a Non-Executive Director to support US market entry. Its near-term commercial focus is hospital and surgical centre adoption in the United States once regulatory clearance is secured.
OSSTEC firmographics
Firmographics- Name
- OSSTEC
- Legal name
- OSSTEC Ltd
- Website
- https://Osstec.uk
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- OSSTEC Ltd is a London-based orthopaedic device company spun out of Imperial College London that develops 3D-printed cementless partial knee implants using biomimetic fixation, selling to hospitals and orthopaedic surgeons and preparing for US market entry pending FDA clearance.
- Ownership category
- akta.pro rank
OSSTEC industry classification
Industry- Product category
- Orthopedic Implants
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
- akta.pro secondary industries
- 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG), Hip & Knee Reconstruction (Arthroplasty) (HLAKALAH)
Keywords
Where OSSTEC is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
OSSTEC business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Medical Device Sales: OSSTEC generates revenue through the sale of 3D printed knee implants and joint replacement technology to healthcare providers and surgical centers
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
OSSTEC product offering
Product offeringCore offering
OSSTEC develops and manufactures 3D-printed knee implants featuring biomimetic cementless fixation technology designed to stimulate bone growth and reduce implant failure. Its flagship ASCENT Cementless Partial Knee System combines 3D-printed articulating surfaces with cementless fixation to enable long-term biologic fixation without cement. The company leverages approximately 10 years of innovation originating at Imperial College London to address high implant loosening and revision rates in joint replacement surgery.
Product overview
OSSTEC offers a focused portfolio of 3D-printed orthopedic implant products built on biomimetic cementless fixation technology. The primary offering is the ASCENT Cementless Partial Knee System, supplemented by 3D printed knee implants that combine innovative articulating surfaces with biomimetic cementless fixation for enhanced functionality and long-lasting bone foundation. The company leverages over 10 years of technological innovation from Imperial College London to improve patient outcomes in joint replacement surgery.
Differentiator
Problem solved
Functional benefit
Products and services
- ASCENT Cementless Partial Knee System OSSTEC's flagship cementless partial knee replacement system designed for orthopedic surgeons and hospitals. It uses biomimetic 3D-printed fixation technology to stimulate bone growth and reduce implant failure risks in knee replacement procedures.
- 3D Printed Knee Implants Knee implants combining 3D-printed articulating surfaces with biomimetic cementless fixation for orthopedic surgeons and hospitals. Designed to provide enhanced functionality, superior fixation, and a long-lasting bone foundation while reducing loosening risk.
Quantifiable outcome
- Cementless implants reduce the risk of loosening by 50%
- +2 more outcomes
Companies that use OSSTEC
Customer profileSegments2 records
Ideal customer profiles1 record
OSSTEC technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
OSSTEC partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
OSSTEC competitors and assessment
Company assessmentBroad incumbents
- Zimmer Biomet: One of the largest orthopedic joint reconstruction players with cementless and partial knee offerings (e.g., Persona Partial). Directly comparable because it targets the same orthopedic surgeons and hospitals for cementless partial knee replacement, though as a broad multi-product incumbent rather than a focused 3D-printed specialist.
- Stryker Corporation: Global orthopedic giant with MAKO robotic knee platform and Triathlon cementless total/partial knee systems. Comparable as it competes in the same cementless knee replacement category with deep hospital sales coverage, but as a multi-product incumbent spanning trauma, joint recon, and robotics.
- Smith & Nephew: Orthopedic joint reconstruction leader with Journey II and Oxford Partial Knee cementless systems. Directly comparable in the partial knee / cementless fixation space, but operates across a much broader orthopedic, sports medicine, and wound care portfolio.
- Enovis Corporation (DJO): Diversified orthopedic and medical technology company with knee and hip reconstruction products. Comparable as a competitor in the orthopedic implant market with sales infrastructure to hospitals and surgical centers, though broader in scope beyond knee.
Direct peers
- restor3d: Patient-specific 3D-printed orthopedic implant company (formerly ConforMIS iTotal/iUni/iDuo). Most directly comparable peer because it uses 3D printing to manufacture cementless, patient-specific knee implants targeting the same hospital and surgeon customers as OSSTEC.
- Bodycad: Canadian patient-specific 3D-printed orthopedic implant company focused on personalized knee and hip reconstruction. Comparable as a small-scale competitor using 3D printing to produce custom orthopedic implants for joint replacement surgery.
Emerging players
- Medacta International: Swiss orthopedic company with cementless knee platforms (GMK Sphere, MyKnee) and a focus on surgeon training (M.O.R.E. Institute). Comparable as an emerging challenger to incumbents with cementless knee technology and a surgeon-training-led GTM similar to OSSTEC's approach.
- Corin Group: UK-based orthopedic company with a hip and knee portfolio including the Unity Partial Knee. Comparable as a mid-sized orthopedic challenger with a focused joint reconstruction portfolio, though based in the UK with similar GTM constraints.
- Waldemar Link: German specialist orthopedic manufacturer with partial knee (LINK Sled) and cementless systems. Comparable as an EMEA-based specialist focused on joint replacement, narrower in scale than Stryker/Zimmer but directly competitive in the partial knee space.
- MicroPort Orthopedics: Orthopedic joint reconstruction company offering the Evolution Medial-Pivot knee system. Comparable as a focused orthopedic challenger targeting knee replacement surgery with an emphasis on differentiation through implant design.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
OSSTEC social profiles
Digital presenceOSSTEC financial estimates
Financial estimateRevenue estimate
Valuation estimate
OSSTEC leadership team
Management profileNumber of profiles
Profiles5 records
OSSTEC funding detail
Funding detailFunding overview
Funding rounds2 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OSSTEC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OSSTEC
What does OSSTEC do?
OSSTEC develops and manufactures 3D-printed knee implants featuring biomimetic cementless fixation technology designed to stimulate bone growth and reduce implant failure. Its flagship ASCENT Cementless Partial Knee System combines 3D-printed articulating surfaces with cementless fixation to enable long-term biologic fixation without cement. The company leverages approximately 10 years of innovation originating at Imperial College London to address high implant loosening and revision rates in joint replacement surgery.
Is OSSTEC a public or private company?
OSSTEC is a private company. It is classified as venture growth investor backed and is currently operating.
When was OSSTEC founded?
OSSTEC was founded in 2021. It employs 1 to 10 people.
Where is OSSTEC based?
OSSTEC is headquartered in London, United Kingdom, in the Europe region.
How does OSSTEC make money?
One revenue line is on record: medical Device Sales.
Who are OSSTEC's main competitors?
Broad incumbents on record are Zimmer Biomet, Stryker Corporation, Smith & Nephew and Enovis Corporation (DJO). Direct peers are restor3d and Bodycad. Emerging players are Medacta International, Corin Group, Waldemar Link and MicroPort Orthopedics.
Does OSSTEC have an API?
No public API is recorded for OSSTEC.
What industry is OSSTEC in?
OSSTEC's product category is Orthopedic Implants. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial). Its NAICS code is 339113 and its SIC code is 3842.